Skip to main content
Clinical Trials/JPRN-UMIN000039518
JPRN-UMIN000039518
Recruiting
Phase 2

The beneficial effects on cognitive function , activities of daily living and QOL using various programs in elderly people. - NRCT

Tohoku University Aging Institute0 sites20 target enrollmentFebruary 22, 2020

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Alzheimer&#39
Sponsor
Tohoku University Aging Institute
Enrollment
20
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 22, 2020
End Date
March 1, 2025
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Tohoku University Aging Institute

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1,Patients who are taking drugs that affect cognitive function(Benzodiazepine,Antideoressant, Central nervous system drugs) 2,Before and after the intervention period, or no intervention period, patients can not join checking items. 3,Patients who are currently join another trial or have joined some within 3 months. 4,Patients who have experienced some interventions when they were at home. 5, Patients who have an animal allergy.

Outcomes

Primary Outcomes

Not specified

Similar Trials